HITTING OF CLINICAL TRIAL DEADLINES ALS Inc., a Full-Contract Research Organization, Specialist of early stage clinical research development solutions, from Phase 0 to Phase 2a, Bioequivalence, Bioavailability and Nutraceutical clinical trial services. At ALS inc. every customer matters, each project is unique as we conduct one study at the time. ALS is a delighted team at the prospect of projects contributing to advance medical research to improve global health. ALS uncompromising commitment of hitting clinical trial deadlines and to complete studies successfully has led Pharmaceuticals to select us for the development of their products. In fact, our extensive experience with studies clinical conduct and our deep knowledge of guidance allow us to gauge how trial protocols manifest in real-life. Sponsors can therefore plan and budget based on accurate projections, they can meet their own deadlines and goals. We gained the reputation of accomplishing complex studies on time and get them done right from the first time. Our studies pass the regulatory review successfully. ALS testing clinic offers a variety of clinical studies driven by Ethics, Guidance and an extensive review: - Phase 0 / First-in-man clinical trials - Phase I (phase 1) clinical trials - Bioavailability and Bioequivalence clinical studies - Nutraceutical clinical studies: we approach them with the same rigor as the phase I clinical studies and in respect of guidance. We have the expertise and the experience with the following therapeutic areas but not limited to: Allergies, Alzheimer, Cardiovascular, Depression, Diabetes, Epilepsy, Gastro-enterology, Hormones, Immunology, Oncology, Osteoporosis, Pain killers, Parkinson, Influenza virus vaccine. Natural health products, functional foods, probiotics. - We are experts in the clinical development process of pharmaceutical drug products and medical devices, we help pharmaceuticals with input, support and writing of white papers writing during this process (publication of study results, graphical presentations for press-release, business plan, funds raising, claim of SR&ED expenses of studies conducted with us, etc.). - Our expertise of Phase I clinical trials is an asset for complex bioequivalence clinical studies. - We use an integrated and secured database and a-24/7 service for reliable and timely subject recruitment. The database contains healthy volunteers and a list of special populations. With our multilingual staff, the study subjects are well informed about the study rules, their rights and their obligations. - Our clinical studies are conducted in collaboration with qualified GLP labs for OTC, Rx medications and natural products. To view the validated analytical methods, click''here''. Visit our facilities: Link 1. Link 2 Should you require any information, we'll be pleased to assisting you: call 1 514 750 6017 or write ''Email''.